2017 ISMP Medication Safety Self Assessment(R) for antithrombotic therapy (Chinese version) (to be continued)
10.3760/cma.j.issn.1008-5734.2019.02.012
- VernacularTitle:2017版ISMP抗血栓药物用药安全自我评估标准(中文版)(待续)
- Author:
Yutong ZONG
1
;
Qingxia ZHANG
;
Yuanyuan YAN
;
Lu LU
;
Chen SHAO
;
Zimin WANG
;
Yujie QIU
;
Suying YAN
Author Information
1. 首都医科大学药学院 北京100069
- Publication Type:Journal Article
- Keywords:
Thrombosis;
Safety;
Drug evaluation;
Hematologic agents;
Warfarin;
Thrombin
- From:
Adverse Drug Reactions Journal
2019;21(2):135-139
- CountryChina
- Language:Chinese
-
Abstract:
The Institute for Safe Medication Practices (ISMP) issued 2017 ISMP Medication Safety Self Assessment(R) for antithrombotic therapy.It was a revision of the 2005 version of the self assessment,mainly including medication safety strategies for the new oral anticoagulants.The 2017 version of the self assessment included 8 key elements and 11 core characteristics,aiming to help the medical institutions assess the medication safety practices of antithrombotic therapy.
